Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
28.6M
-
Shares change
-
-3.36M
-
Total reported value, excl. options
-
$72.3M
-
Value change
-
-$8.63M
-
Put/Call ratio
-
0.63
-
Number of buys
-
25
-
Number of sells
-
-34
-
Price
-
$2.53
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q1 2020
77 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q1 2020.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.6M shares
of 52.3M outstanding shares and own 54.66% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.62M shares), Evermore Global Advisors, LLC (4.01M shares), BlackRock Inc. (3.65M shares), RENAISSANCE TECHNOLOGIES LLC (3.31M shares), VANGUARD GROUP INC (2.26M shares), DIMENSIONAL FUND ADVISORS LP (2.07M shares), WELLINGTON MANAGEMENT GROUP LLP (1.69M shares), ARIEL INVESTMENTS, LLC (870K shares), STATE STREET CORP (759K shares), and GEODE CAPITAL MANAGEMENT, LLC (560K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.